Daniel M. Siegel, MS, MD, FAAD
SESSIONS
No sessions scheduled for this speaker.
HANDOUTS
DISCLOSURES
Avita – Advisory Board(Honoraria), Consultant(Honoraria); Biofrontera AG – Stockholder(Stock); Caliber Imaging and Diagnostics Inc. – Board of Directors(Stock); Cara Therapeutics – Advisory Board(Honoraria); DermaSensor Inc – Consultant(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Feldan Therapeutics – Consultant(Fees); Greenway Therapeutix – Advisory Board(No Compensation Received), Stockholder(Stock); Lazarus Enterprises Inc. – Consultant(Stock Options); Logical Images – Consultant(Stock Options); Medforce Technologies, Inc. – Consultant(Fees); Modernizing Medicine – Advisory Board(Stock); MycoMedica Life Sciences – Advisory Board(No Compensation Received); Novascan – Stockholder(No Compensation Received); Or-Genix, Therapeutics – Board of Directors(Stock Options), Stockholder(No Compensation Received); Plasmend – Stockholder(No Compensation Received); Pulse Biosciences – Consultant(Fees); RaMedical – Stockholder(No Compensation Received); RBC Consultants – Consultant (1099 relationship)(Honoraria); Regeneron – Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi Genzyme – Speaker(Honoraria); SciBASE – Consultant(Fees); Seaspire Skincare – Consultant(Stock Options); SkinVision – Advisory Board(Stock Options); SPC Dermatology – Employee(Salary); Strata Skin Sciences – Consultant(Fees); Tetros Group – Advisory Board(No Compensation Received), Stockholder(No Compensation Received); Verrica Pharmaceuticals Inc – Consultant(Fees);